173 related articles for article (PubMed ID: 16235573)
1. BeadArray-based solutions for enabling the promise of pharmacogenomics.
Fan JB; Hu SX; Craumer WC; Barker DL
Biotechniques; 2005 Oct; 39(4):583-8. PubMed ID: 16235573
[TBL] [Abstract][Full Text] [Related]
2. BeadArray-based solutions for enabling the promise of pharmacogenomics.
Fan JB; Hu S; Craumer W; Barker D
Biotechniques; 2005 Oct; 39(10 Suppl):S583-8. PubMed ID: 18957041
[TBL] [Abstract][Full Text] [Related]
3. Clinical applications of microarray-based diagnostic tests.
Wu L; Williams PM; Koch WH
Biotechniques; 2005 Oct; 39(4):577-82. PubMed ID: 16235572
[TBL] [Abstract][Full Text] [Related]
4. Whole genome genotyping technologies on the BeadArray platform.
Steemers FJ; Gunderson KL
Biotechnol J; 2007 Jan; 2(1):41-9. PubMed ID: 17225249
[TBL] [Abstract][Full Text] [Related]
5. Pharmacogenomics and nutrigenomics: synergies and differences.
Ghosh D; Skinner MA; Laing WA
Eur J Clin Nutr; 2007 May; 61(5):567-74. PubMed ID: 17213870
[TBL] [Abstract][Full Text] [Related]
6. [Pharmacogenetics II. Research molecular methods, bioinformatics and ethical concerns].
Daudén E
Actas Dermosifiliogr; 2007; 98(1):3-13. PubMed ID: 17374327
[TBL] [Abstract][Full Text] [Related]
7. The integration of personalized and systems medicine: bioinformatics support for pharmacogenomics and drug discovery.
Yan Q
Methods Mol Biol; 2008; 448():1-19. PubMed ID: 18370227
[TBL] [Abstract][Full Text] [Related]
8. The promise of pharmacogenetics: assessing the prospects for disease and patient stratification.
Smart A; Martin P
Stud Hist Philos Biol Biomed Sci; 2006 Sep; 37(3):583-601. PubMed ID: 16980196
[TBL] [Abstract][Full Text] [Related]
9. Personalized medicine.
Jain KK
Curr Opin Mol Ther; 2002 Dec; 4(6):548-58. PubMed ID: 12596356
[TBL] [Abstract][Full Text] [Related]
10. Human genetic variation and personalized medicine.
Agrawal S; Khan F
Indian J Physiol Pharmacol; 2007; 51(1):7-28. PubMed ID: 17877289
[TBL] [Abstract][Full Text] [Related]
11. Microarray-based DNA profiling to study genomic aberrations.
Waddell N
IUBMB Life; 2008 Jul; 60(7):437-40. PubMed ID: 18553550
[TBL] [Abstract][Full Text] [Related]
12. [A new approach to pharmacogenomics].
Fujita Y
Nihon Yakurigaku Zasshi; 2000 Sep; 116(3):149-57. PubMed ID: 11031744
[TBL] [Abstract][Full Text] [Related]
13. Foundations, promises and uncertainties of personalized medicine.
Bottinger EP
Mt Sinai J Med; 2007 Apr; 74(1):15-21. PubMed ID: 17516562
[TBL] [Abstract][Full Text] [Related]
14. Pharmacogenetics/genomics and personalized medicine.
Sadée W; Dai Z
Hum Mol Genet; 2005 Oct; 14 Spec No. 2():R207-14. PubMed ID: 16244319
[TBL] [Abstract][Full Text] [Related]
15. The Affymetrix DMET platform and pharmacogenetics in drug development.
Deeken J
Curr Opin Mol Ther; 2009 Jun; 11(3):260-8. PubMed ID: 19479659
[TBL] [Abstract][Full Text] [Related]
16. Enabling pharmacogenomics: survey shows researchers looking for new solutions.
Expert Rev Mol Diagn; 2002 Nov; 2(6):528. PubMed ID: 12465449
[No Abstract] [Full Text] [Related]
17. SNP market view: opportunities, technologies, and products.
Wypgant M
Biotechniques; 2002 Jun; Suppl():78-80, 82, 84 passim. PubMed ID: 12083402
[No Abstract] [Full Text] [Related]
18. Pharmacogenetics: the Dx perspective.
Cartwright CP
Expert Rev Mol Diagn; 2001 Nov; 1(4):371-6. PubMed ID: 11901851
[TBL] [Abstract][Full Text] [Related]
19. Prospects for personalized cardiovascular medicine: the impact of genomics.
Ginsburg GS; Donahue MP; Newby LK
J Am Coll Cardiol; 2005 Nov; 46(9):1615-27. PubMed ID: 16256859
[TBL] [Abstract][Full Text] [Related]
20. Applications of microarrays and biochips in pharmacogenomics.
Hardiman G
Methods Mol Biol; 2008; 448():21-30. PubMed ID: 18370228
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
